A public-private partnership between ARPA-H and VentureWell in support of the ARPANET-H nationwide health innovation network. Website is maintained by VentureWell staff.
ARPA-H Program Manager Paul E. Sheehan, Ph.D., will join the Investor Catalyst Hub’s virtual monthly meeting to discuss the various programs in his portfolio—including Resilient Extended Automatic Cell Therapies (REACT)—as well as his scientific area of expertise. Prior to joining ARPA-H in February 2023, Dr. Sheehan served as Program Manager in the Biological Technologies Office at the Defense Advanced Research Projects Agency (DARPA), where his research focused on leveraging developments in synthetic biology to detect and address threats to human health, including novel pathogens in the environment and microbial imbalances in the gut. Don’t miss this opportunity to learn more about Dr. Sheehan’s areas of research interest and to connect with him for live Q&A.